Predictors of failed left bundle branch pacing implant in heart failure with reduced ejection fraction: importance of left ventricular diameter and QRS morphology.

cardiac resynchronization therapy intraventricular conduction delay left bundle branch pacing left ventricular diameter successful implant

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
19 Jun 2024
Historique:
received: 05 04 2024
revised: 31 05 2024
accepted: 13 06 2024
medline: 22 6 2024
pubmed: 22 6 2024
entrez: 21 6 2024
Statut: aheadofprint

Résumé

Left bundle branch pacing (LBBP) is considered an alternative to cardiac resynchronization therapy (CRT). However, LBBP is not suitable for all heart failure patients. The aim of our study was to identify predictors of unsuccessful LBBP implantation in CRT candidates. A cohort of consecutive patients with indications for CRT were included. Clinical, echocardiography and electrocardiography variables were prospectively recorded. A total of 187 patients were included in the analysis. LBBP implantation was successful in 152/187 (81.2%) patients and failed in 35/187 (18.7%) patients. The causes of unsuccessful implantation were unsatisfactory paced QRS (28/35; 80%), inability to screw the helix (4/35; 11.4%), lead instability (2/35; 5.7%), and high pacing thresholds (1/35; 2.8%). The left ventricular end diastolic diameter (LVEDD), non-LBBB (left bundle branch block) QRS morphology, and QRS width were predictors of failed implantation according to the univariate analysis. According to the multivariable regression analysis, LVEDD [OR 1.31 per 5 mm increase (95% CI 1.05, 1.63) p=0.02] and non-LBBB [OR 3.07 (95% CI 1.08, 8.72) p=0.03] were found to be independent predictors of unsuccessful LBBP implantation. An LVEDD of 60 mm has 60% sensitivity and 71% specificity for predicting LBBP implant failure. When LBBP was used as CRT, LVEDD and non-LBBB QRS morphology predicted unsuccessful implantation. Non-LBBB triples the likelihood of failed implantation independent of LVEDD. Caution should be taken when considering these parameters to plan the best pacing strategy for patients.

Sections du résumé

BACKGROUND BACKGROUND
Left bundle branch pacing (LBBP) is considered an alternative to cardiac resynchronization therapy (CRT). However, LBBP is not suitable for all heart failure patients.
OBJECTIVE OBJECTIVE
The aim of our study was to identify predictors of unsuccessful LBBP implantation in CRT candidates.
METHODS METHODS
A cohort of consecutive patients with indications for CRT were included. Clinical, echocardiography and electrocardiography variables were prospectively recorded.
RESULTS RESULTS
A total of 187 patients were included in the analysis. LBBP implantation was successful in 152/187 (81.2%) patients and failed in 35/187 (18.7%) patients. The causes of unsuccessful implantation were unsatisfactory paced QRS (28/35; 80%), inability to screw the helix (4/35; 11.4%), lead instability (2/35; 5.7%), and high pacing thresholds (1/35; 2.8%). The left ventricular end diastolic diameter (LVEDD), non-LBBB (left bundle branch block) QRS morphology, and QRS width were predictors of failed implantation according to the univariate analysis. According to the multivariable regression analysis, LVEDD [OR 1.31 per 5 mm increase (95% CI 1.05, 1.63) p=0.02] and non-LBBB [OR 3.07 (95% CI 1.08, 8.72) p=0.03] were found to be independent predictors of unsuccessful LBBP implantation. An LVEDD of 60 mm has 60% sensitivity and 71% specificity for predicting LBBP implant failure.
CONCLUSIONS CONCLUSIONS
When LBBP was used as CRT, LVEDD and non-LBBB QRS morphology predicted unsuccessful implantation. Non-LBBB triples the likelihood of failed implantation independent of LVEDD. Caution should be taken when considering these parameters to plan the best pacing strategy for patients.

Identifiants

pubmed: 38906515
pii: S1547-5271(24)02731-0
doi: 10.1016/j.hrthm.2024.06.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Freddy R Graterol (FR)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Margarida Pujol-López (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Roger Borràs (R)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red; Salud Mental (CIBERSAM), Instituto de Salut Carlos III, Madrid, Spain.

Bernardo Ayala (B)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain.

Laura Uribe (L)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain.

Eduard Guasch (E)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Mariona Regany-Closa (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Mireia Niebla (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Esther Carro (E)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain.

Jean-Baptiste Guichard (JB)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

M Ángeles Castel (MÁ)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Elena Arbelo (E)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Andreu Porta-Sánchez (A)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain.

Marta Sitges (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Josep Brugada (J)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Ivo Roca-Luque (I)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Adelina Doltra (A)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Lluís Mont (L)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

José M Tolosana (JM)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. Electronic address: tolosana@clinic.cat.

Classifications MeSH